Skip to content

Clinical trials

Multiple Sclerosis trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Country / region: Lithuania Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20111
20131
20144
20153
20161
20171
20182
20191
20211
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Actelion2
Biogen2
Celgene2
Merck KGaA, Darmstadt, Germany2
Sanofi2
Teva Branded Pharmaceutical Products R&D, Inc.2
EMD Serono Research & Development Institute, Inc.1
Fondazione Don Carlo Gnocchi ETS1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis23
Multiple Sclerosis, Relapsing-Remitting4
Recurrence3
Multiple Sclerosis, Chronic Progressive2
Brain Injuries, Traumatic1
Fatigue1
Spinal Cord Injuries1
Stroke1
Thinness1

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.